The Multicenter Study for Effects of Eplerenone on Cardiac Diastolic Dysfunction in Hypertensive Patients

Trial Profile

The Multicenter Study for Effects of Eplerenone on Cardiac Diastolic Dysfunction in Hypertensive Patients

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Apr 2017

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Diastolic heart failure; Hypertension
  • Focus Biomarker; Pharmacodynamics
  • Acronyms MELODY
  • Most Recent Events

    • 03 Apr 2017 Planned End Date changed from 1 Jan 2015 to 30 Jun 2017.
    • 27 Mar 2016 Status changed from recruiting to active, no longer recruiting.
    • 09 Oct 2013 Planned number of patients changed from 400 to 180 as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top